Early, intensive statin treatment reduces 'hard' cardiovascular outcomes after acute coronary syndrome

European Journal of Preventive Cardiology

Volumn 24, Issue 12, 2017, Pages 1294-1296

  Schwartz, Gregory G ^a   Fayyad, Rana ^b   Szarek, Michael ^c   Demicco, David ^b   Olsson, Anders G ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

acute coronary syndrome; Statin

Indexed keywords

ATORVASTATIN; PLACEBO; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); DEATH; HEART ARREST; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; POST HOC ANALYSIS; PRIORITY JOURNAL; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; CAUSE OF DEATH; DOSE RESPONSE; GLOBAL HEALTH; MORBIDITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY PREVENTION; TRENDS;

ACUTE CORONARY SYNDROME; CAUSE OF DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; GLOBAL HEALTH; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MORBIDITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SECONDARY PREVENTION;

EID: 85025081590     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487317708677     Document Type: Article

References (6)

1. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2889-2934.
2. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001; 285: 1711-1718.
3. Briel M, Vale N, Schwartz GG, et al. Updated evidence on early statin therapy for acute coronary syndromes: meta-analysis of 18 randomized trials involving over 14,000 patients. Int J Cardiol 2012; 158: 93-100.
4. Anker SD, Schroeder S, Atar D, et al. Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency. Eur J Heart Fail 2016; 18: 482-489.
5. Kumana CR, Cheung BM, Lauder IJ,. Gauging the impact of statins using number needed to treat. JAMA 1999; 282: 1899-1901.
6. Arnold SV, Kosiborod M, Tang F, et al. Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction. Circulation 2014; 129: 1303-1309.